A team led by Duke biochemistry professor Bruce Donald, PhD, has developed an algorithm to predict how mutations in an enzyme will affect a drug’s efficacy.
The Donald Lab, led by Bruce Donald, PhD, is designing proteins for a historically undruggable protein that’s implicated in difficult-to-treat cancers like pancreatic cancer.